Tolerance to the Diuretic Effects of Cannabinoids and Cross-Tolerance to a κ-Opioid Agonist in THC-Treated Mice
- PMID:27231154
- PMCID: PMC4959092
- DOI: 10.1124/jpet.116.232132
Tolerance to the Diuretic Effects of Cannabinoids and Cross-Tolerance to a κ-Opioid Agonist in THC-Treated Mice
Abstract
Daily treatment with cannabinoids results in tolerance to many, but not all, of their behavioral and physiologic effects. The present studies investigated the effects of 7-day exposure to 10 mg/kg daily of Δ(9)-tetrahydrocannabinol (THC) on the diuretic and antinociceptive effects of THC and the synthetic cannabinoid AM4054. Comparison studies determined diuretic responses to the κ-opioid agonist U50,488 and furosemide. After determination of control dose-response functions, mice received 10 mg/kg daily of THC for 7 days, and dose-response functions were re-determined 24 hours, 7 days, or 14 days later. THC and AM4054 had biphasic diuretic effects under control conditions with maximum effects of 30 and 35 ml/kg of urine, respectively. In contrast, antinociceptive effects of both drugs increased monotonically with dose to >90% of maximal possible effect. Treatment with THC produced 9- and 7-fold rightward shifts of the diuresis and antinociception dose-response curves for THC and, respectively, 7- and 3-fold rightward shifts in the AM4054 dose-response functions. U50,488 and furosemide increased urine output to >35 ml/kg under control conditions. The effects of U50,488 were attenuated after 7-day treatment with THC, whereas the effects of furosemide were unaltered. Diuretic effects of THC and AM4054 recovered to near-baseline levels within 14 days after stopping daily THC injections, whereas tolerance to the antinociceptive effects persisted longer than 14 days. The tolerance induced by 7-day treatment with THC was accompanied by a 55% decrease in the Bmax value for cannabinoid receptors (CB1). These data indicate that repeated exposure to THC produces similar rightward shifts in the ascending and descending limbs of cannabinoid diuresis dose-effect curves and to antinociceptive effects while resulting in a flattening of the U50,488 diuresis dose-effect function.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.
Figures





Similar articles
- Diuretic effects of cannabinoids.Paronis CA, Thakur GA, Bajaj S, Nikas SP, Vemuri VK, Makriyannis A, Bergman J.Paronis CA, et al.J Pharmacol Exp Ther. 2013 Jan;344(1):8-14. doi: 10.1124/jpet.112.199331. Epub 2012 Sep 27.J Pharmacol Exp Ther. 2013.PMID:23019138Free PMC article.
- Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein-Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with Δ9-Tetrahydrocannabinol and JWH-018.Ford BM, Cabanlong CV, Tai S, Franks LN, Penthala NR, Crooks PA, Prather PL, Fantegrossi WE.Ford BM, et al.J Pharmacol Exp Ther. 2019 May;369(2):259-269. doi: 10.1124/jpet.118.252965. Epub 2019 Mar 4.J Pharmacol Exp Ther. 2019.PMID:30833484Free PMC article.
- Combined Treatment with Morphine and Δ9-Tetrahydrocannabinol in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal.Gerak LR, France CP.Gerak LR, et al.J Pharmacol Exp Ther. 2016 May;357(2):357-66. doi: 10.1124/jpet.115.231381. Epub 2016 Mar 2.J Pharmacol Exp Ther. 2016.PMID:26937020Free PMC article.
- NTP Developmental and Reproductive Toxicity Technical Report on the Prenatal Development Studies of 2-((1-(4-Phenoxyphenoxy)propan-2-yl)oxy)pyridine (CASRN 95737-68-1) in Sprague Dawley (Hsd:Sprague Dawley® SD®) Rats and New Zealand White (Hra:NZW SPF) Rabbits: DART Report 07 [Internet].National Toxicology Program.National Toxicology Program.Research Triangle Park (NC): National Toxicology Program; 2022 Jan.Research Triangle Park (NC): National Toxicology Program; 2022 Jan.PMID:35593777Free Books & Documents.Review.
- Domperidone.[No authors listed][No authors listed]2025 Jan 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–.2025 Jan 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–.PMID:30000430Free Books & Documents.Review.
Cited by
- The nephrologist's guide to cannabis and cannabinoids.Rein JL.Rein JL.Curr Opin Nephrol Hypertens. 2020 Mar;29(2):248-257. doi: 10.1097/MNH.0000000000000590.Curr Opin Nephrol Hypertens. 2020.PMID:31972598Free PMC article.Review.
- Stimulation of diuresis and natriuresis by renomedullary infusion of a dual inhibitor of fatty acid amide hydrolase and monoacylglycerol lipase.Ahmad A, Daneva Z, Li G, Dempsey SK, Li N, Poklis JL, Lichtman A, Li PL, Ritter JK.Ahmad A, et al.Am J Physiol Renal Physiol. 2017 Nov 1;313(5):F1068-F1076. doi: 10.1152/ajprenal.00196.2017. Epub 2017 Aug 2.Am J Physiol Renal Physiol. 2017.PMID:28768662Free PMC article.
- Long-Lasting In Vivo Effects of the Cannabinoid CB1 Antagonist AM6538.Paronis CA, Chopda GR, Vemuri K, Zakarian AS, Makriyannis A, Bergman J.Paronis CA, et al.J Pharmacol Exp Ther. 2018 Mar;364(3):485-493. doi: 10.1124/jpet.117.245647. Epub 2018 Jan 8.J Pharmacol Exp Ther. 2018.PMID:29311110Free PMC article.
- Mechanisms of cannabinoid tolerance.Piscura MK, Henderson-Redmond AN, Barnes RC, Mitra S, Guindon J, Morgan DJ.Piscura MK, et al.Biochem Pharmacol. 2023 Aug;214:115665. doi: 10.1016/j.bcp.2023.115665. Epub 2023 Jun 20.Biochem Pharmacol. 2023.PMID:37348821Free PMC article.Review.
- Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice.Wilson CD, Tai S, Ewing L, Crane J, Lockhart T, Fujiwara R, Radominska-Pandya A, Fantegrossi WE.Wilson CD, et al.J Pharmacol Exp Ther. 2019 Feb;368(2):146-156. doi: 10.1124/jpet.118.251157. Epub 2018 Nov 12.J Pharmacol Exp Ther. 2019.PMID:30420360Free PMC article.
References
- Ames F. (1958) A clinical and metabolic study of acute intoxication with Cannabis sativa and its role in the model psychoses. J Ment Sci 104:972–999. - PubMed
- Bass CE, Martin BR. (2000) Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice. Drug Alcohol Depend 60:113–119. - PubMed
- Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Vogt LJ, Sim-Selley LJ. (1999) Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain. J Neurochem 73:2447–2459. - PubMed
- Budney AJ, Moore BA, Vandrey RG, Hughes JR. (2003) The time course and significance of cannabis withdrawal. J Abnorm Psychol 112:393–402. - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources